SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-22-060657
Filing Date
2022-09-30
Accepted
2022-09-30 16:01:13
Documents
12
Period of Report
2022-09-28
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea166524-8k_emmauslife.htm   iXBRL 8-K 22078
  Complete submission text file 0001213900-22-060657.txt   189135

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE emma-20220928.xsd EX-101.SCH 3266
3 XBRL LABEL FILE emma-20220928_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE emma-20220928_pre.xml EX-101.PRE 22385
6 EXTRACTED XBRL INSTANCE DOCUMENT ea166524-8k_emmauslife_htm.xml XML 3291
Mailing Address 21250 HAWTHORNE BOULEVARD, SUITE 800 TORRANCE CA 90503
Business Address 21250 HAWTHORNE BOULEVARD, SUITE 800 TORRANCE CA 90503 310-214-0065
Emmaus Life Sciences, Inc. (Filer) CIK: 0000822370 (see all company filings)

IRS No.: 870419387 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35527 | Film No.: 221283966
SIC: 2834 Pharmaceutical Preparations